Physician profile
Tejaskumar Shah
NPI 1871721076
$7,053.20
in general payments reported to CMS, 2019-2025
39 companies · $1,109 in 2025
The $1,109 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $376 · 2021: $810 · 2022: $1,166 · 2023: $2,390 · 2024: $884 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,776 · Travel and Lodging: $607 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,776.23 |
| Travel and Lodging | $607.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,412.89 | 2019-2025 | Varithena Administration Pack, Avvigo Guidance System, Ekosonic |
| Edwards Lifesciences Corporation | $749.65 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $609.14 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.81 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $287.22 | 2021-2024 | Verquvo |
| Teleflex LLC | $277.51 | 2023 | Guideliner |
| Cook Medical LLC | $255.63 | 2020-2023 | Zilver Ptx, Advance |
| Abiomed | $245.09 | 2020-2025 | |
| Shockwave Medical, INC | $205.67 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $204.28 | 2021-2025 | Camzyos, Eliquis |
| Bard Peripheral Vascular, INC. | $198.21 | 2023-2025 | Rotarexs 6 F X 135 Cm |
| Cardiovascular Systems INC. | $187.12 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $172.64 | 2023-2025 | |
| Atricure, INC. | $149.86 | 2021-2023 | |
| Penumbra, INC. | $142.80 | 2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejaskumar Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.